Cargando…

The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis

BACKGROUND AND AIMS: Glucose phosphate isomerase (GPI) deficiency is an extremely rare autosomal recessive disorder caused by mutations in the GPI gene. In this research, the proband displaying typical manifestations of haemolytic anaemia and his family members were recruited to analyse the pathogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Liu, Tao, Liu, Jiaqi, Xiang, Yan, Huang, Lan, Li, Jiacheng, An, Xizhou, Cui, Shengyan, Feng, Zishuai, Yu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332073/
https://www.ncbi.nlm.nih.gov/pubmed/37430284
http://dx.doi.org/10.1186/s12920-023-01603-x
_version_ 1785070370178465792
author Wang, Yang
Liu, Tao
Liu, Jiaqi
Xiang, Yan
Huang, Lan
Li, Jiacheng
An, Xizhou
Cui, Shengyan
Feng, Zishuai
Yu, Jie
author_facet Wang, Yang
Liu, Tao
Liu, Jiaqi
Xiang, Yan
Huang, Lan
Li, Jiacheng
An, Xizhou
Cui, Shengyan
Feng, Zishuai
Yu, Jie
author_sort Wang, Yang
collection PubMed
description BACKGROUND AND AIMS: Glucose phosphate isomerase (GPI) deficiency is an extremely rare autosomal recessive disorder caused by mutations in the GPI gene. In this research, the proband displaying typical manifestations of haemolytic anaemia and his family members were recruited to analyse the pathogenicity of the detected variants. METHODS: Peripheral blood samples were collected from the family members and genomic DNA was extracted and targeted for capture and sequencing. The effect of the candidate pathogenic variants on splicing was further investigated using the minigene splicing system. The computer simulation was also used for further analysis of the detected data. RESULTS: The proband carried the compound heterozygous variants c.633 + 3 A > G and c.295G > T in the GPI gene, which have never been reported before. In the genealogy, co-segregation of the mutant genotype with the phenotype was established. The minigene study showed that intronic mutations resulted in abnormal pre-mRNA splicing. Specifically, the two aberrant transcripts: r.546_633del and r.633 + 1_633 + 2insGT were transcribed by the minigene plasmid expressing the c.633 + 3 A > G variant. The missense mutation c.295G > T in exon 3 resulted in altering glycine at codon 87 to cysteine which was predicted to be pathogenic in an in silico analysis. Deeper analyses revealed that the Gly87Cys missense mutation led to steric hindrance. Compared to the wild-type, the mutation G87C led to a significant increase in intermolecular forces. CONCLUSION: Overall, the novel compound heterozygous variants in the GPI gene contributed to the etiology of the disease. Genetic testing can assist in the diagnosis. The novel gene variants identified in the present study has further expanded the mutational spectrum of GPI deficiency, which can better guide family counselling. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01603-x.
format Online
Article
Text
id pubmed-10332073
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103320732023-07-11 The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis Wang, Yang Liu, Tao Liu, Jiaqi Xiang, Yan Huang, Lan Li, Jiacheng An, Xizhou Cui, Shengyan Feng, Zishuai Yu, Jie BMC Med Genomics Research BACKGROUND AND AIMS: Glucose phosphate isomerase (GPI) deficiency is an extremely rare autosomal recessive disorder caused by mutations in the GPI gene. In this research, the proband displaying typical manifestations of haemolytic anaemia and his family members were recruited to analyse the pathogenicity of the detected variants. METHODS: Peripheral blood samples were collected from the family members and genomic DNA was extracted and targeted for capture and sequencing. The effect of the candidate pathogenic variants on splicing was further investigated using the minigene splicing system. The computer simulation was also used for further analysis of the detected data. RESULTS: The proband carried the compound heterozygous variants c.633 + 3 A > G and c.295G > T in the GPI gene, which have never been reported before. In the genealogy, co-segregation of the mutant genotype with the phenotype was established. The minigene study showed that intronic mutations resulted in abnormal pre-mRNA splicing. Specifically, the two aberrant transcripts: r.546_633del and r.633 + 1_633 + 2insGT were transcribed by the minigene plasmid expressing the c.633 + 3 A > G variant. The missense mutation c.295G > T in exon 3 resulted in altering glycine at codon 87 to cysteine which was predicted to be pathogenic in an in silico analysis. Deeper analyses revealed that the Gly87Cys missense mutation led to steric hindrance. Compared to the wild-type, the mutation G87C led to a significant increase in intermolecular forces. CONCLUSION: Overall, the novel compound heterozygous variants in the GPI gene contributed to the etiology of the disease. Genetic testing can assist in the diagnosis. The novel gene variants identified in the present study has further expanded the mutational spectrum of GPI deficiency, which can better guide family counselling. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01603-x. BioMed Central 2023-07-10 /pmc/articles/PMC10332073/ /pubmed/37430284 http://dx.doi.org/10.1186/s12920-023-01603-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Yang
Liu, Tao
Liu, Jiaqi
Xiang, Yan
Huang, Lan
Li, Jiacheng
An, Xizhou
Cui, Shengyan
Feng, Zishuai
Yu, Jie
The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
title The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
title_full The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
title_fullStr The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
title_full_unstemmed The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
title_short The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
title_sort novel compound heterozygous variants identified in a chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332073/
https://www.ncbi.nlm.nih.gov/pubmed/37430284
http://dx.doi.org/10.1186/s12920-023-01603-x
work_keys_str_mv AT wangyang thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT liutao thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT liujiaqi thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT xiangyan thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT huanglan thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT lijiacheng thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT anxizhou thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT cuishengyan thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT fengzishuai thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT yujie thenovelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT wangyang novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT liutao novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT liujiaqi novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT xiangyan novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT huanglan novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT lijiacheng novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT anxizhou novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT cuishengyan novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT fengzishuai novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis
AT yujie novelcompoundheterozygousvariantsidentifiedinachinesefamilywithglucosephosphateisomerasedeficiencyandpathogenicityanalysis